Infectious disease modeler and biostatistician Ira Longini is applying decades of experience to help design and analyze clinical trials to identify a safe and effective COVID-19 vaccine.
Patients with severe cases of COVID-19 who were treated with the investigational drug remdesivir recovered faster than those who did not take it, based on results released this week of an international clinical trial that included UF Health.
As researchers continue to unravel the mysteries of COVID-19, they are increasingly realizing the disease caused by the novel coronavirus often involves more than the lungs that it ravages.